Tag Archives: market report

Although long overlooked, exosomes are rapidly gaining momentum as a novel strategy for accessing the therapeutic effects of stem cells without the risks and difficulties of administering the cells to patients. Although exosomes were discovered more than 30 years ago, ...

The fusion of plasma membrane with the internal vesicle fusion leads to the secretion of nanovescicles called exosomes into the extracellular environment. The exosomes are released in easily accessible body fluids such as urine and blood and hence acts as ...

The global liquid biopsy market is segmented into biomarkers such as circulating tumor cells (CTCs), extracellular vesicles (Exosomes) and cell-free circulating DNA (cfDNA). Among these segments, circulating tumor cells (CTCs) segment is expected to occupy top position in overall liquid ...

BusinessWire – Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. A revolution in ...

Widespread acceptance of liquid biopsy technique in North America and steady adoption in developing regions is expected to drive global liquid biopsy market revenues. The global market is expected to reach US$ 407 Mn in 2016, up from US$ 351 ...

Research and Markets has announced the addition of the “Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic Markets 2016-2020” report to their offering. A revolution in cancer diagnostics is occurring using in vitro blood testing to identify ...

The report “Liquid Biopsy Market – Forecast to 2021“, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the liquid biopsy market along with the estimates and forecasts of the revenue. Download ...

Research and Markets has announced the “Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic Markets 2016-2020” report. A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. GRAIL, a new company ...

Liquid biopsy primarily focuses on the detection, isolation and characterization of biomarkers from circulating tumor cells (CTCs), circulating tumor DNA (ctDNA) or exosomes present in biological fluids, which can be collected in a single blood draw. Primarily driven by liquid ...

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Exosome Diagnostics and Therapeutics: Global Markets” report to their offering. The global market for exosome diagnostics and therapeutics is projected to grow from $16.1 million in 2016 to $111.8 million ...